Longeveron

Longeveron 是一家在股票代码 LGVN (US) 下上市的公司。

查看带有其 17 名主要高管的组织结构图

Longeveron 搜索最多的简介

• Wa'el Hashad, Chief Executive Officer and Director
• Ursula Ungaro, Director
• Rock Soffer, Director

高管在Longeveron变化

• Devin Blass已作为Chief Technology Officer and Senior Vice President of Chemistry, Manufacturing and Controls加入公司  (新闻发布的2024十一月12号).
• Roger Hajjar已作为Director加入公司  (新闻发布的2024七月9号).
• Cathy Ross, Director, 已经离开公司  (新闻发布的2024五月13号).

更多的变化在％s

创建提醒
跟踪 Longeveron 的高管变动

Longeveron 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。

Popular M&A news in 生物技术

• Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
• Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
• Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).

生物技术 行业的其他推荐联系人

• Scholar Rock 企业 Kristina Burow - Director
• UroGen 企业 Fred Cohen - Director
• VBI Vaccines 企业 Steven Gillis - Chairman of the Board

了解更多有关生物技术行业的信息 >

Longeveron 的最新新闻稿

• Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update
• Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC)
• Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
• Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)
• Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting
• Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)
• Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day
• Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting
• Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
• Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
• View more press releases Close

关于 Longeveron 的社交媒体

• Longeveron 在 维基百科、谷歌新闻 和 雅虎财经
• Longeveron 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Wa'el Hashad

致电Longeveron，电话：+1 305...

查看组织结构图

Register to receive your alert

报告错误